Broadening the Therapeutic Armamentarium Against Plaque Psoriasis
Podcast 2
Post-Test/Evaluation

Questions marked with a * are required
19%
Contact Information
Credentials/Degree (MD, DO, RN, etc.)
Date of  Participation
A 20-year-old man presents to dermatology with severe psoriasis (13% body surface area) on his
face, chest, back, arms, and legs. He has tried topical OTC agents and hydrocortisone cream.
When discussing systemic treatment for this patient, he voices that he doesn’t want treatment
requiring injections. Which of the following agents – recently approved based on positive PASI 75
and PASI 90 data versus apremilast – might make the most sense for him?
When talking to patients about treatment, it is critical to understand individual patient goals.
Data show that which of the following is the most critical patient-reported treatment goal?
Powered by QuestionPro